ONWARD planerar webbsändning för att ge affärsuppdatering för halvåret 2023
05 sept. 2023 20h23 HE
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), medicinteknikföretaget som skapar innovativa terapier för att återställa rörelse, funktion och självständighet hos...
Webcast ONWARD pianifica per fornire un aggiornamento aziendale semestrale 2023
05 sept. 2023 20h23 HE
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), la società di tecnologia medica che crea terapie innovative per ripristinare il movimento, la funzione e...
ONWARD plant Webcast zur Bereitstellung eines Geschäftsupdates für das Halbjahr 2023
05 sept. 2023 20h23 HE
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), das Medizintechnikunternehmen, das innovative Therapien zur Wiederherstellung von Bewegung, Funktion und...
ONWARD prévoit une webdiffusion pour fournir une mise à jour semestrielle 2023
05 sept. 2023 20h23 HE
|
ONWARD Medical
Eindhoven, 05 sept. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), la société de technologie médicale qui crée des thérapies innovantes pour restaurer le mouvement, la fonction et...
ONWARD plant webcast om halfjaarlijkse 2023 business update te geven
05 sept. 2023 20h23 HE
|
ONWARD Medical
Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medisch technologiebedrijf dat innovatieve therapieën creëert om beweging, functie en onafhankelijkheid te...
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
04 sept. 2023 16h00 HE
|
Celyad Oncology SA
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging...
BioCorRx Reports Business Update for the Second Quarter of 2023
14 août 2023 16h34 HE
|
BioCorRx Inc
On Track to Meet 2023 Regulatory Milestones ANAHEIM, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...
Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
14 août 2023 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
BiondVax Reports Second Quarter Financial Results and Provides Business Update
11 août 2023 09h00 HE
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- via IBN - BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative...
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
10 août 2023 08h00 HE
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at...